CA2257931C - Forme modifiee de l'hydrochlorure de l'acide r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotique - Google Patents

Forme modifiee de l'hydrochlorure de l'acide r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotique Download PDF

Info

Publication number
CA2257931C
CA2257931C CA002257931A CA2257931A CA2257931C CA 2257931 C CA2257931 C CA 2257931C CA 002257931 A CA002257931 A CA 002257931A CA 2257931 A CA2257931 A CA 2257931A CA 2257931 C CA2257931 C CA 2257931C
Authority
CA
Canada
Prior art keywords
hydrochloride
methylthien
enyl
hydrochloric acid
tiagabine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002257931A
Other languages
English (en)
Other versions
CA2257931A1 (fr
Inventor
Preben Ahrndt
Henning Borge Petersen
Vincent H. Chang
Kimberly Ann Allen
Michael H. Chain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Priority claimed from PCT/DK1997/000244 external-priority patent/WO1997047619A1/fr
Publication of CA2257931A1 publication Critical patent/CA2257931A1/fr
Application granted granted Critical
Publication of CA2257931C publication Critical patent/CA2257931C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne l'hydrochlorure de l'acide R(-)-N-(4,4-di(3-méthylthién-2-yl)but-3-ényl)-nipécotique, sous forme anhydre pure et stable.
CA002257931A 1996-06-14 1997-06-03 Forme modifiee de l'hydrochlorure de l'acide r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotique Expired - Fee Related CA2257931C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK66196 1996-06-14
DK0661/96 1996-06-14
PCT/DK1997/000244 WO1997047619A1 (fr) 1996-06-14 1997-06-03 Forme modifiee de l'hydrochlorure de l'acide r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotique

Publications (2)

Publication Number Publication Date
CA2257931A1 CA2257931A1 (fr) 1997-12-18
CA2257931C true CA2257931C (fr) 2006-12-12

Family

ID=37561099

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002257931A Expired - Fee Related CA2257931C (fr) 1996-06-14 1997-06-03 Forme modifiee de l'hydrochlorure de l'acide r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotique

Country Status (1)

Country Link
CA (1) CA2257931C (fr)

Also Published As

Publication number Publication date
CA2257931A1 (fr) 1997-12-18

Similar Documents

Publication Publication Date Title
US5958951A (en) Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
AU777987B2 (en) Hydrochloride salts of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione
EP0579681B1 (fr) Monohydrate d'hydrochlorure de tiagabine cristalline, sa preparation et son utilisation
EP0906309B1 (fr) Forme modifiee de l'hydrochlorure de l'acide r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotique
AU2004238537A1 (en) Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
WO2002053135A1 (fr) Base libre d'amlodipine
BE1014454A6 (nl) Amlodipinehemimaleaat.
CA2257931C (fr) Forme modifiee de l'hydrochlorure de l'acide r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotique
US7335380B2 (en) Amlodipine free base
KR100491636B1 (ko) R(-)-n-[4,4-디(3-메틸티엔-2-일)부트-3-엔일)-니페코트산염산염의변형된형태
CZ20014270A3 (cs) Polymorfy krystalického citrátu (2-benzhydryl-1-azabicyklo[2.2.2]oct-3-yl)-(5-iso-propyl-2-methoxybenzyl)-aminu jako antagonisté receptoru NK-1
EP1355632B1 (fr) Base libre d'amlodipine
AU2001100436A4 (en) Amlodipine hemimaleate
NL1018759C1 (nl) Amlodipinehemimaleaat.
SI21067A2 (sl) Amlodipin hemimaleat
CZ12566U1 (cs) Amlodipinhemimaleát a farmaceutický prostředek
EP1640374A1 (fr) Sels de pioglitazone tels que le sulfate de pioglitazone, et leurs compositions pharmaceutiques et leurs procédés d'utilisation
CZ12614U1 (cs) Amlodipinmaleát a farmaceutický prostředek
SI21068A2 (sl) Amlodipin maleat ali njegova kislinska adicijska sol

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130604

MKLA Lapsed

Effective date: 20130604